TrialEmerging microbes & infections2021

Safety and immunogenicity of a recombinant interferon-armed RBD dimer vaccine (V-01) for COVID-19 in healthy adults: a randomized, double-blind, placebo-controlled, Phase I trial.

Jikai Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.